The convergence of artificial intelligence (AI) and medicine has led to a new era of innovation in biomedical research. GPT-4, an AI model, has been widely used in ChatGPT for biomedical simulations.

In Vienna, Austria, MedUni Vienna has demonstrated the potential of ChatGPT in biomedical research by developing a simulator based on GPT-4. This simulator has shown improved precision in classifying the significance of genes in cancer cells and predicting cancer prognosis. 

GPT-4 has become valuable in biomedicine. Researchers from MedUni Vienna have highlighted various applications of GPT-4 as a simulator for biological systems. They tested the hypothesis that using GPT-4 for simulating biological and medical processes leads to better outcomes. The researchers also developed "SimulateGPT," a simulation method that uses structured inputs in GPT-4 for various scenarios, such as mouse experiments, sepsis treatment support, and cancer patient analysis.

In the field of biomedicine, modern models like ChatGPT/GPT-4 are good at responding to simple queries, but can struggle with more complex scenarios. Scientists at MedUni Vienna configured GPT-4 with structured inputs and specific instructions to perform detailed text-based simulations. This approach led to significantly improved results and garnered favorable reviews from biomedical experts.

Dr. Matthias Samwald emphasizes the potential for language models like GPT-4 to create biomedical simulators. He suggests several directions for further development, such as integrating biological databases and training AI models with empirical data. 

The work done at MedUni Vienna represents a significant advance in the field of biomedical simulations, pointing towards revolutionary advancements in understanding and managing complex biological systems.